NPCE

Healthcare Medical Devices

NeuroPace, Inc.

$12.93
-0.11 -0.82% today Live

Price History

Not enough data
Price chart data
DatePrice
Oct 6, 2026, live at 3:15 PM ET12.93

Key Stats

Market Cap
443.81M
Avg Volume
172,090
EPS
-$0.57
52W High
$19.60
52W Low
$9.22
Div. Yield
0.0%

Analyst Ratings

Buy
1
Str Buy
9
Buy
0
Hold
0
Sell
0
Str Sell

Valuation

Forward P/E
-59.45
P/B Ratio
37.26
P/S Ratio
4.15
EV/EBITDA
-39.74
EV/Revenue
4.41

Margins

Gross Margin 77.4%
Operating Margin (22.5%)
Net Margin (17.9%)
EBITDA Margin (11.1%)

Growth & Returns

Revenue Growth (YoY)
17.1%
Return on Equity
(103.3%)
Return on Assets
(7.5%)

Liquidity & Leverage

Current Ratio
4.94
Quick Ratio
3.82
Debt / Equity
5.88
Total Cash
51.70M
Total Debt
69.93M

About

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

www.neuropace.com